People Newspapers
A smaller dose of the COVID-19 vaccine produced by Pfizer and BioNTech produced a safe and “robust” immune response in children ages 5-11 in a clinical trial, the company said Monday morning.
(Read time: 3.9 minutes)
The U.S. Food and Drug Administration (FDA) this week expanded the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents 12 through 15 years of age.
Read more
After President Joe Biden announced that the country would begin a shift from mass vaccination efforts to more tailored options in more neighborhoods, Texas health officials began making changes to the way COVID vaccines are distributed, too.
Read more
The City of Dallas Department of Aviation and MCI Diagnostic Center have partnered to bring a COVID-19 testing and vaccine site to Dallas Love Field.
Read more
One group of school-aged children may be able to get a COVID vaccination within the next couple of weeks, and an even younger cohort will likely be able to be immunized in the fall.
Read more
The Texas Department of State Health Services in a letter Friday urged vaccine providers to order additional shots as needed.
Read more
The U.S. Tuesday recommended a “pause” in the use of the Johnson & Johnson COVID-19 vaccine as the Centers for Disease Control and Prevention and FDA investigate six cases of rare blood clots among the more than 6.8 million Americans who received the shot.
Read more
President Joe Biden Tuesday announced that anyone 16 or older will be eligible to receive the COVID-19 vaccine by April 19, but also warned that even though vaccinations are happening at a rapid clip, it’s not quite the time to relax efforts to reduce the spread.
Read more
Clinical trial results of the Pfizer/BioNTech’s COVID-19 vaccine show it’s 100% effective at preventing infection in adolescents between 12 and 15 years old, the companies announced Wednesday.
Read more
Sometime today, Dallas County will adminster its 250,000th COVID-19 vaccination, and the relative speed when it comes to how quickly the vaccines went from development to vials and syringes is still a big discussion.
Read more
The Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines are highly effective at preventing infection in real-world conditions, a new report from the Centers for Disease Control and Prevention showed.
Read more